Current News

News

04/01/24

Acupuncture for Chronic Low Back Pain

Since January 21, 2020, the Centers for Medicare and Medicaid Services (CMS) covers acupuncture for chronic low back pain for up to 12 visits in 90 days. If patients are demonstrating improvement, CMS will cover an additional 8 visits for a total of 20 visits annually. Beginning with dates of service on and after January 1, 2024, CMS will

Read More
09/21/20

TRICARE to Initiate LPB Demonstration Project

The Director, Defense Health Agency (DHA), has approved the creation of a demonstration to waive cost-sharing for up to three physical therapy (PT) visits for TRICARE beneficiaries with low back pain (LBP). Dates of the DemonstrationThis demonstration project will be effective Demonstration StatesThe following states were selected as demonstration states: Description of the Demonstration Provider Requirements under the Demonstration Purpose of the Demonstration Other Relevant Details To read all about the demonstration project, click I hope you found this article informative and helpful. Thank you for being a Gold Member!

Read More
06/08/20

Does Medicare Now Pay for Dry Needling

Effective January 1, 2020, there were 2 new CPT codes to describe dry needling. They are as follows: 20560 – Needle insertion(s) without injection(s), 1 or 2 muscle(s) 20561 – Needle insertion(s) without injection(s), 3 or more muscle(s) Unfortunately, the Centers for Medicare and Medicaid Services (CMS) gave these 2 CPT codes a non-covered status for payment under the Medicare Physician Fee Schedule (MPFS). This meant that if a physical therapist performed dry needling on a Medicare beneficiary who had traditional Medicare as their insurance, CMS would not pay for this service. Since dry needling is non-covered by CMS, this

Read More
07/17/19

CMS Proposes to Cover Acupuncture for CLBP

On July 15, 2019, the Centers for Medicare & Medicaid Services (CMS) released a proposal to cover acupuncture for Medicare patients with chronic low back pain (CLBP) who are enrolled participants either in clinical trials sponsored by the National Institutes of Health (NIH) or in CMS-approved studies. To read the proposed decision memo, click HERE. To submit comments on the proposed decision memo, click HERE.

Read More